Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma M&A announcement today. The $132-per-share agreement comes a few months ...
Bens Appliances and Junk Official on MSN
Whirlpool washer lid lock won't work - how to replace W11513248 / W11414731 assembly
This is a very new style of lid lock in 2023 from Whirlpool, and also works on Maytag Washing machines like the Maytag Pet ...
Latin America’s outbound investment is surging, and a majority of that capital is staying within the region. In 2024, 65% of all outward FDI projects (by value) were directed toward other Latin ...
The Seattle Seahawks made a big change at quarterback this offseason, as they traded Geno Smith to the Las Vegas Raiders and replaced him by signing Sam Darnold to a three-year, $100.5 million ...
If you have the space for a full home laundry setup, you’re in the right place. This guide will help you find the best washer and dryer set 2025 has to offer, featuring trusted brands like Speed Queen ...
India vs India A Live Streaming, Intra-Squad match: The artist in Kuldeep Yadav would look to keep an accurate Ravindra Jadeja on toes when both the slow left-arm bowlers take the field during the ...
Advances Company’s industry-leading portfolio in mental health with addition of CAPLYTA ® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an ...
We may receive a commission on purchases made from links. Smart Locks are slowly becoming must-have options for smart home fans. They offer the typical deadbolt security of a regular lock while giving ...
Johnson & Johnson JNJ0.98%increase; green up pointing triangle agreed to acquire mental-illness drug developer Intra-Cellular Therapies for about $15 billion, evidence of the pharmaceutical industry’s ...
Johnson & Johnson said on Monday it would buy drugmaker Intra-Cellular Therapies for $14.6 billion, boosting its presence in the market for neurological disorder treatments. J&J will buy all of ...
Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s closing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results